AllianceBernstein’s Aktis Oncology AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$349K Buy
+17,900
New +$436K ﹤0.01% 2880

Other funds holding AKTS

AllianceBernstein's AKTS Position: Q3 2026 in Review

AllianceBernstein opened a new position in Aktis Oncology (AKTS) in Q3 2026: 17,900 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings.

122 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • AllianceBernstein held 17,900 shares of Aktis Oncology worth $349K as of Q3 2026.
  • Aktis Oncology was a new AllianceBernstein position in Q3 2026.
  • Aktis Oncology made up ﹤0.01% of AllianceBernstein's portfolio in Q3 2026, its #2880 holding.
  • 122 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on AllianceBernstein's 13F filing for Q3 2026, filed 16 Nov 2026.